openPR Logo
Press release

Antibody-drug Conjugates Market Is Set To Experience Revolutionary Growth By 2027 | ImmunoGen, Seattle Genetics, Roche, Takeda

04-27-2020 06:47 AM CET | Health & Medicine

Press release from: Stratagem Market Insights

Antibody-drug Conjugates Market

Antibody-drug Conjugates Market

The research report on the "Antibody-drug Conjugates Market 2020" offers a holistic analysis of the business space, in tandem with a comprehensive overview of market segmentation. The report details the market scenario according to industry size and current position as well as volume and revenue with forecast to 2027. The study also emphasizes the crucial insights regarding the geographical as well as the competitive landscape of the market. The new report offers a powerful combination of the latest, in-depth research studies on the Antibody-drug Conjugates market. The authors of the report are highly experienced analysts and possess deep market knowledge. Some of the key players in the Global Antibody-drug Conjugates market are ImmunoGen, Seattle Genetics, Roche, Takeda.

Download Sample Pages of the Antibody-drug Conjugates Market Report here: https://www.stratagemmarketinsights.com/sample/11604

[**NOTE: This report Sample includes;
o Brief Introduction to the research report
o Table of Contents (Scope covered as a part of the study)
o Top players in the market
o Research framework (presentation)
o Research methodology adopted by Stratagem Market Insights]

Antibody-drug conjugates are class of highly potent biological drugs that combine monoclonal antibodies specific to surface antigens which are present on particular tumor cells with highly potent anti-cancer agents associated with a chemical linker. These drugs are especially used to treat cancer by targeting and killing tumor cells while sparing healthy cells present around. These drugs offer very high specificity to the targeted cells while maximizing their efficacy and minimizing the side-effects associated. Blood cancer, lung cancer, breast cancer, and brain tumor are some of the major application areas of antibody-drug conjugates.

Rising prevalence of cancer around the globe due unhealthy lifestyle is expected to propel the market growth of antibody-drug conjugates over the forecast period. According to the World Health Organization, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Moreover, the rising number of partnerships among major players for developing and commercializing the advanced antibody-drug conjugates is further expected to foster market growth. For instance, in March 2019, AstraZeneca has entered into a development and commercialization collaboration agreement with Daiichi Sankyo Company, Limited (Daiichi Sankyo) for trastuzumab deruxtecan (DS-8201), an antibody-drug conjugate (ADC) and potential new targeted medicine for cancer treatment.

Competitive Analysis:

The report covers major players operating in the Antibody-drug Conjugates market along with the key strategies implemented to achieve a competitive edge against a majority of the vendors which provides a competitive outlook of the industry. The competitive landscape further includes details about different players and their position on a global and a local level is also explained in detail in this compiled study. These insights were prepared through mapping business strategies and products that offer high revenue generation capacities.

Top players including;

o ImmunoGen
o Seattle Genetics
o Roche
o Takeda

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

o Adcetris
o Kadcyla

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Antibody-drug Conjugates for each application, including

o Breast Cancer
o Lymphoma

Don't miss out on business opportunities in Antibody-drug Conjugates Market. Buy Now and gain crucial industry insights that will help your business grow: https://www.stratagemmarketinsights.com/cart/11604

The key strategic developments of the Antibody-drug Conjugates market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the Antibody-drug Conjugates market on a global and regional basis. The study provides a decisive view of the Antibody-drug Conjugates market by segmenting the market based on product, end-user, and regions. All the segments have been analyzed based on present and future trends and the Antibody-drug Conjugates market is estimated from 2020 to 2027. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation into major countries.

Global Antibody-drug Conjugates Market Report includes Detailed TOC points:

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Global Antibody-drug Conjugates Market
2 Market Segmentation
3 Market Overview
3.1 Rising Government Initiatives
3.2 Strategic Initiative By Market Players
4 Executive Summaries
5 Premium Insights
6 Regulatory Procedure
7 Global Antibody-drug Conjugates Market, By Type
8 Global Antibody-drug Conjugates Market, by Application
9 Global Antibody-drug Conjugates Market, By Deployment
10 Global Antibody-drug Conjugates Market, By End User
11 Global Antibody-drug Conjugates Market, By Distribution Channel
12 Global Antibody-drug Conjugates Market, Company Landscape
13 Company Profile
13.1 Company Snapshot
13.2 Revenue Analysis
13.3 Company Share Analysis
13.4 Product Portfolio

Customization of this Report: This Antibody-drug Conjugates research report could be customized to the customer's requirements. We will ensure you obtain the report which works for your needs.

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Inquire Now (Kindly Use Your Business/Corporate Email Id) @ https://www.stratagemmarketinsights.com/quiry/11604

Thanks a million for reading! You can also request custom information like chapter-wise or specific region-wise study as per your interest.

Contact us:

Mr. Shah
Stratagem Market Insights
Tel: +1 415 871 0703
Email: sales@stratagemmarketinsights.com
Visit Here @ S_Blogs

About Us:

Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with a cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. Our reports cover various end-use industries such as Aerospace and Defense, Agriculture, Food and Beverages, Automotive, Chemicals and Materials, Consumer Goods and Retail, Electronics, Energy, Mining, and Utilities, Pharmaceuticals, Manufacturing and Construction, Services, and Healthcare, and ICT.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antibody-drug Conjugates Market Is Set To Experience Revolutionary Growth By 2027 | ImmunoGen, Seattle Genetics, Roche, Takeda here

News-ID: 2025063 • Views:

More Releases from Stratagem Market Insights

Workable Strategic Report on Hospital Capacity Management Solutions Market In-Depth Insights In New Research Report 2023-2030 | Top Players: Awarepoint, Allscripts Healthcare, Cerner
Workable Strategic Report on Hospital Capacity Management Solutions Market In-De …
Stratagem Market Insights introducing our highly anticipated "Hospital Capacity Management Solutions Market" research report 'Navigating the Future: Uncovering Market Insights for Success.' This comprehensive report is an indispensable resource for businesses seeking to thrive in today's dynamic and competitive landscape. With a wealth of meticulously gathered data, expert analysis, and actionable recommendations, this Hospital Capacity Management Solutions market report offers a deep dive into market trends, consumer behavior, and emerging
Top Key Players and Factors Driving Telematics For On-Highway Vehicles Market Growth for from 2023 to 2030 | Robert Bosch GmbH (Germany), Continental AG (Germany)
Top Key Players and Factors Driving Telematics For On-Highway Vehicles Market Gr …
Stratagem Market Insights (SMI), a leading provider of market intelligence solutions, is pleased to announce the release of its latest market research report titled "Telematics For On-Highway Vehicles Market Report 2023 - Emerging Trends and Growth Forecast to 2030." This comprehensive report offers a detailed analysis of the Telematics For On-Highway Vehicles, providing valuable insights and strategic recommendations for businesses operating in the sector. The Telematics For On-Highway Vehicles Market Report
Forecast for Commercial Drone-Enabled Services Market Shows Exponential Growth with Comprehensive SWOT Analysis from 2023 to 2030 | 3D Robotics, AeroVironment, DJI, Leptron
Forecast for Commercial Drone-Enabled Services Market Shows Exponential Growth w …
Stratagem Market Insights, a leading provider of market research and analysis, is proud to announce the release of its latest comprehensive market research report titled "Commercial Drone-Enabled Services Market Research Report 2023 - Unveiling Key Insights and Trends." This groundbreaking report offers valuable insights and trends in this sector, providing businesses and stakeholders with a deep understanding of the market dynamics and growth opportunities. Backed by extensive data analysis and expert
Software Repository Market: Top Key Vendors' Analysis and Predictions for Global Trends from 2023 to 2030
Software Repository Market: Top Key Vendors' Analysis and Predictions for Global …
"Stratagem Market Insights offers a 70% discount on Software Repository Market Reports on Single User Access and Unlimited User Access" SMI has recently published a new research report titled "Software Repository Market - Global Outlook and Forecast till 2030." This report offers a comprehensive analysis of the market, drawing insights from historical milestones and current trends. It presents a detailed examination of production volumes for each type from 2018 to 2030,

All 5 Releases


More Releases for Conjugates

Global Cancer Antibody Drug Conjugates Market
Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030 Report Finding & Inclusions: • Global Cancer Antibody Drug Conjugates Market: 2020 - 2030 • Global Cancer Antibody Drug Conjugates Market Opportunity > US$ 50 Billion By 2030 • Approved Cancer Antibody Drug Conjugates: 16 Drugs • Approved Cancer Antibody Drug Conjugates Sales Insights, Patent, Dosage and Price Analysis • Cancer Antibody Drug Conjugates In Clinical Trials: > 500 Drugs • Cancer Antibody Drug Conjugates Clinical
Bispecific Antibody Drug Conjugates Development
The development of bispecific antibody drug conjugates (ADCs) marks a significant advancement in the field of targeted cancer therapy. These innovative molecules combine the specificity of bispecific antibodies with the powerful cytotoxic effects of drug conjugates, creating a new class of therapeutic agents that hold great promise for treating complex and resistant cancers. The process of developing these ADCs involves intricate design, engineering, and testing to ensure their safety, efficacy,
DLL3 Antibody-Drug Conjugates: Mechanisms and Efficacy
Antibody-drug conjugates (ADCs) represent a revolutionary approach in cancer treatment, combining the targeting capabilities of antibodies with the cytotoxic power of chemotherapy. DLL3 (Delta-Like Ligand 3) has emerged as a promising target for ADCs, particularly in the treatment of small cell lung cancer (SCLC) and other neuroendocrine tumors. This article explores the mechanisms and efficacy of DLL3 ADCs, shedding light on their potential in modern oncology. Download Report: https://www.kuickresearch.com/report-dll3-targeted-therapies-dll3-cancer-therapies-dll3-protien-dll3-cancer-drugs-delta-like-ligand-3-dll3-gene-dll3-expression-dll3-amgen-dll3-inhibitor DLL3 is a
Radionuclide Drug Conjugates (RDC) Market Minimizing Side Effects, Maximizing Im …
Radionuclide Drug Conjugates (RDCs) Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook
Oncology Antibody Drug Conjugates Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Oncology Antibody Drug Conjugates Market is projected to grow from USD 9.87 billion in 2022 to USD 22.48 billion at a CAGR value of 12.4% from 2022 to 2027. Pfizer Inc., Astellas Pharma Inc., Gilead Sciences, Inc., GlaxoSmithKline, F. Hoffmann-La Roche AG, Daiichi Sankyo, AstraZeneca, Sanofi, AbbVie, Merck & Co., Byondis, RemeGen, ImmunoGen, Seagen, Rakuten Medical,
Global Antibody Drug Conjugates Market Insights, Forecast
Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement